INO vs INTU · $88.0M cap vs P/E 64, rev $18.83B
Inovio Pharmaceuticals Inc (INO) versus Intuit Inc (INTU) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Intuit Inc (INTU) is a software - application company listed on US.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
INO currently screens at market cap $88.0M. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Not investment advice. Open the INO and INTU stock pages for the full models.
Not investment advice.